Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 17, 2020
Glucagon receptor signaling is not required for N-carbamoyl glutamate- and l-citrulline-induced ureagenesis in miceKatrine D Galsgaard, Jens Pedersen, Sasha A S Kjeldsen, et al.Diabetes|June 3, 2022
The Liver-α-Cell Axis in Health and in DiseaseMichael M Richter, Katrine D Galsgaard, Emilie Elmelund, et al.Peptides|April 11, 2024
Glucagon does not directly stimulate pituitary secretion of ACTH, GH or copeptinIda Stangerup, Sasha A S Kjeldsen, Michael M Richter, et al.Scandinavian Journal of Clinical and Laboratory Investigation|December 22, 2021
On measurements of glucagon secretion in healthy, obese, and Roux-en-Y gastric bypass operated individuals using sandwich ELISANicolai J Wewer Albrechtsen, Sasha A S Kjeldsen, Nicole J Jensen, et al.Journal of the Endocrine Society|February 21, 2024
Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 DiabetesMichael M Richter, Mads N Thomsen, Mads J Skytte, et al.Herz|July 1, 2006
ESH-ESC guidelines for the management of hypertensionSerap Erdine, Oben Ari, A Zanchetti, et al.American Journal of Hypertension|July 1, 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupB Dahlöf, R Devereux, U de Faire, et al.Journal of Human Hypertension|August 31, 2007
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to actionG Bakris, M Hill, G Mancia, et al.Journal of the Endocrine Society|October 11, 2023
Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 DiabetesSasha A S Kjeldsen, Mads N Thomsen, Mads J Skytte, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|August 6, 2024
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver diseaseSasha A S Kjeldsen, Mikkel P Werge, Josephine Grandt, et al.Pageof 4